Related Experiment Video
Updated: Jun 21, 2026

Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
Blood pressure, dementia and Alzheimer's disease: the OPTIMA longitudinal study
George Razay1, Jonathan Williams, Elizabeth King
1Dementia Research Centre, Launceston General Hospital, University of Tasmania, Launceston, Tas., Australia. george.razay@dhhs.tas.gov.au
Insights
Both high and low blood pressure (BP) levels are linked to faster cognitive decline in Alzheimer's disease (AD) patients. This finding may inform future prevention and treatment strategies for AD.
Area of Science:
- Neurology
- Gerontology
- Cardiovascular Health
Background:
- Previous research on blood pressure (BP) and dementia, including Alzheimer's disease (AD), has produced conflicting findings.
- Some studies suggest associations with high BP, others with low BP, and some report no association.
Purpose of the Study:
- To investigate the longitudinal impact of blood pressure on cognitive function.
- To examine the relationship between BP parameters and cognitive decline in patients with dementia and healthy controls.
Main Methods:
- Utilized data from the OPTIMA longitudinal study, including cognitively healthy controls and patients with dementia.
- Measured cognitive function using the Cambridge Cognitive Examination (CAMCOG) and recorded blood pressure.
- Employed generalized linear mixed models to analyze the dependence of CAMCOG scores on BP.
Main Results:
- The study included 235 cognitively healthy controls, 42 with mild cognitive impairment (MCI), 141 with AD, and 59 with other dementia syndromes (ODS).
- In AD patients, cognitive decline (CAMCOG scores) exhibited an inverted U-shaped, non-linear relationship with diastolic BP.
- Both high (110 mm Hg) and low (60 mm Hg) diastolic BP levels were associated with accelerated cognitive decline over 5 years (p = 0.012).
- Cognitive scores also showed an inverted U-shaped dependence on pulse pressure (p = 0.022).
Conclusions:
- Elevated and reduced blood pressure levels are significantly associated with faster cognitive decline in individuals with Alzheimer's disease.
- These findings highlight the potential importance of BP management in the prevention and treatment of AD.
Background/Aims:
Studies on the relation between blood pressure (BP), dementia and Alzheimer's disease (AD) have yielded inconsistent results, showing an association with high or low BP, or no association with BP. The study was designed to look at the longitudinal effect of BP on cognitive function.
Methods:
Participants were part of the OPTIMA longitudinal study of patients with dementia and agematched cognitively healthy controls. The Cambridge Cognitive Examination (CAMCOG) and BP were measured. We tested the dependence of CAMCOG scores on BP using generalised linear mixed models.
Results:
A total of 235 were cognitively healthy controls, 42 had mild cognitive impairment (MCI), 141 had AD, and 59 had other dementia syndrome (ODS). In AD patients, the rate of decline of CAMCOG scores showed an inverted U-shaped (non-linear) dependence on diastolic BP. High (110 mm Hg) and low (60 mm Hg) levels of diastolic BP were related to faster cognitive decline over 5 years of follow-up (z = -2.51, p = 0.012). CAMCOG scores also showed an inverted U-shaped dependence on pulse pressure (z = -2.29, p = 0.022).
Conclusion:
High and low BP levels are related to faster cognitive decline in AD patients. This could have implications for the prevention and treatment of AD.
Related Concept Videos
Dementia l: Introduction
Alzheimer Disease l: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies
Factors affecting Blood pressure
Physiological Factors:
Hypertension and Regulation of Blood Pressure
Measurement of Blood Pressure